Join Us at FIME 2023: AllTest's Latest Innovations on Display

图片2(1).png


We are excited to announce that Hangzhou AllTest Biotech Co.,Ltd. will be participating in the upcoming FIME exhibition in June. This event is one of the largest medical trade shows in the United States, and we are thrilled to have the opportunity to showcase our latest products and developments in the healthcare industry.

 

About FIME

 

FIME has become the premier platform for medical device and equipment manufacturers and suppliers to showcase their products and services, network with industry peers, and gain insight into the latest trends and developments in the healthcare industry. The event attracts thousands of attendees from across the Americas and beyond, making it an ideal opportunity to forge new partnerships and collaborations.

 

This year's event promises to be bigger and better than ever before, with over 1,200 exhibitors and 25,000 attendees expected to participate. The program will feature a wide range of educational sessions, product demonstrations, and networking opportunities, all designed to foster collaboration and innovation in the healthcare industry.

 

Hangzhou AllTest Biotech Co.,Ltd. at FIME 2023

 

Hangzhou AllTest Biotech Co.,Ltd. is delighted to once again participate in the premier trade show for the medical device and equipment industry in the Americas. This event provides an unparalleled opportunity for healthcare professionals and suppliers to come together, share knowledge, and explore new solutions to the challenges facing the industry. We look forward to showcasing our latest research and development at our booth on June 21, 2023, and providing attendees with an exciting display of POCT products.

 

BOOTH NO. :I51


图片3(1).png


We cordially invite you to visit our booth at the FIME exhibition and learn more about our innovative medical testing solutions. Our team of experts will be on hand to provide product demonstrations and answer any questions you may have about our range of products.


Recommend

Last:

Next:

Return